Skip to main content

05.04.2024 | Narrative review

Acute kidney injury in acute liver failure: A narrative review

verfasst von: Brij Sharma, Anshul Bhateja, Rajesh Sharma, Ashish Chauhan, Vishal Bodh

Erschienen in: Indian Journal of Gastroenterology

Einloggen, um Zugang zu erhalten

Abstract

Acute kidney injury (AKI) is a frequent complication of acute liver failure (ALF) and it worsens the already worse prognoses of ALF. ALF is an uncommon disease, with varying etiologies and varying definitions in different parts of the world. There is limited literature on the impact of AKI on the outcome of ALF with or without transplantation. The multifaceted etiology of AKI in ALF encompasses factors such as hemodynamic instability, systemic inflammation, sepsis and direct nephrotoxicity. Indications of renal replacement therapy (RRT) for AKI in ALF patients extend beyond the conventional criteria for dialysis and continuous renal replacement therapy (CRRT) may have a role in transplant-free survival or bridge to liver transplantation (LT). LT is a life-saving option for ALF, so despite somewhat lower survival rates of LT in ALF patients with AKI, LT is not usually deferred. In this review, we will discuss the guidelines’ recommended definition and classification of AKI in ALF, the impact of AKI in ALF, the pathophysiology of AKI and the role of CRRT and LT in ALF patients with AKI.
Literatur
1.
Zurück zum Zitat Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023;118:1128–53.CrossRefPubMed Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023;118:1128–53.CrossRefPubMed
2.
Zurück zum Zitat Lee WM, Larson AM, Stravitz RT. AASLD position paper: the management of acute liver failure: update 2011. Hepatology. 2011;55:965–7.CrossRef Lee WM, Larson AM, Stravitz RT. AASLD position paper: the management of acute liver failure: update 2011. Hepatology. 2011;55:965–7.CrossRef
3.
Zurück zum Zitat Anand AC, Nandi B, Acharya SK, et al. Indian National Association for the Study of the Liver consensus statement on acute liver failure (Part 1): epidemiology, pathogenesis, presentation and prognosis. J Clin Exp Hepatol. 2020;10:339–76.CrossRefPubMedPubMedCentral Anand AC, Nandi B, Acharya SK, et al. Indian National Association for the Study of the Liver consensus statement on acute liver failure (Part 1): epidemiology, pathogenesis, presentation and prognosis. J Clin Exp Hepatol. 2020;10:339–76.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Anand AC, Nandi B, Acharya SK, et al. INASL task-force on acute liver failure. Indian National Association for the Study of Liver consensus statement on acute liver failure (part-2) management of acute liver failure. J Clin Exp Hepatol. 2020;10:477–517. Anand AC, Nandi B, Acharya SK, et al. INASL task-force on acute liver failure. Indian National Association for the Study of Liver consensus statement on acute liver failure (part-2) management of acute liver failure. J Clin Exp Hepatol. 2020;10:477–517.
5.
Zurück zum Zitat Wendon J, Cordoba J, Dhawan A, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66:1047–81.CrossRefPubMed Wendon J, Cordoba J, Dhawan A, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66:1047–81.CrossRefPubMed
6.
Zurück zum Zitat Tandon BN, Bernauau J, O’Grady J. Recommendations of the International Association for the Study of the Liver subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol. 1999;14:403–4. Tandon BN, Bernauau J, O’Grady J. Recommendations of the International Association for the Study of the Liver subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol. 1999;14:403–4.
7.
Zurück zum Zitat O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273–5.CrossRefPubMed O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273–5.CrossRefPubMed
9.
Zurück zum Zitat Feldman M, Friedman LS, Bandt LJ, et al. Acute liver failure, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 11th ed. In: O'Grady J, Bernal W, editors. Philadelphia: Elsevier; 2021. p. 1499–508. Feldman M, Friedman LS, Bandt LJ, et al. Acute liver failure, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 11th ed. In: O'Grady J, Bernal W, editors. Philadelphia: Elsevier; 2021. p. 1499–508.
10.
Zurück zum Zitat Tujios SR, Hynan LS, Vazquez MA, et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol. 2015;13:352–9. Tujios SR, Hynan LS, Vazquez MA, et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol. 2015;13:352–9.
11.
Zurück zum Zitat Hadem J, Kielstein JT, Manns MP, et al. Outcomes of renal dysfunction in patients with acute liver failure. United Eur Gastroenterol J. 2019;7:388–96. Hadem J, Kielstein JT, Manns MP, et al. Outcomes of renal dysfunction in patients with acute liver failure. United Eur Gastroenterol J. 2019;7:388–96.
12.
Zurück zum Zitat Urrunaga NH, Magder LS, Weir MR, et al. Prevalence, severity, and impact of renal dysfunction in acute liver failure on the US liver transplant waiting list. Dig Dis Sci. 2016;61:309–16. Urrunaga NH, Magder LS, Weir MR, et al. Prevalence, severity, and impact of renal dysfunction in acute liver failure on the US liver transplant waiting list. Dig Dis Sci. 2016;61:309–16.
13.
Zurück zum Zitat Acharya SK, Dasarathy S, Kumer TL, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology. 1996;23:1448–55.CrossRefPubMed Acharya SK, Dasarathy S, Kumer TL, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology. 1996;23:1448–55.CrossRefPubMed
14.
Zurück zum Zitat Kumar R, Shalimar, Bhatia V, et al. Anti-tuberculosis therapy induced acute liver failure: magnitude, profile, prognosis and predictors of outcome. Hepatology. 2010;51:1665–74. Kumar R, Shalimar, Bhatia V, et al. Anti-tuberculosis therapy induced acute liver failure: magnitude, profile, prognosis and predictors of outcome. Hepatology. 2010;51:1665–74.
15.
Zurück zum Zitat Khuroo MS, Kamili S. Aetiology and prognostic factors in acute liver failure in India. J Viral Hep. 2003;10:224–31.CrossRef Khuroo MS, Kamili S. Aetiology and prognostic factors in acute liver failure in India. J Viral Hep. 2003;10:224–31.CrossRef
16.
Zurück zum Zitat Coelho S, Fonseca JN, Gameiro J, Jorge S, Velosa J, Lopes JA. Transient and persistent acute kidney injury in acute liver failure. J Nephrol. 2019;32:289–96. Coelho S, Fonseca JN, Gameiro J, Jorge S, Velosa J, Lopes JA. Transient and persistent acute kidney injury in acute liver failure. J Nephrol. 2019;32:289–96.
17.
Zurück zum Zitat Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009;58:443–9.CrossRefPubMed Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009;58:443–9.CrossRefPubMed
18.
Zurück zum Zitat Angeli P, Gines P, Wong F, et al. International club of ascites. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut. 2015;64:531–7. Angeli P, Gines P, Wong F, et al. International club of ascites. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut. 2015;64:531–7.
19.
Zurück zum Zitat Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure. Zhonghua Gan Zang Bing Za Zhi. 2019;27:18–26. Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure. Zhonghua Gan Zang Bing Za Zhi. 2019;27:18–26.
20.
Zurück zum Zitat Escorsell A, Castellote J, Sa´nchez-Delgado J, et al. Management of acute liver failure: clinical guideline from the Catalan Society of Digestology. Gastroenterol Hepatol. 2019;42:51–64.CrossRefPubMed Escorsell A, Castellote J, Sa´nchez-Delgado J, et al. Management of acute liver failure: clinical guideline from the Catalan Society of Digestology. Gastroenterol Hepatol. 2019;42:51–64.CrossRefPubMed
21.
Zurück zum Zitat Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR. News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document. J Hepatol. 2019;71:811–22. Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR. News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document. J Hepatol. 2019;71:811–22.
22.
Zurück zum Zitat Leventhal TM, Liu KD. What a nephrologist needs to know about acute liver failure. Adv Chronic Kidney Dis. 2015;22:376–81. Leventhal TM, Liu KD. What a nephrologist needs to know about acute liver failure. Adv Chronic Kidney Dis. 2015;22:376–81.
23.
Zurück zum Zitat Siniscalchi A, Dante A, Spedicato S, et al. Hyperdynamic circulation in acute liver failure: reperfusion syndrome and outcome following liver transplantation. Transpl Proc. 2010;42:1197–9. Siniscalchi A, Dante A, Spedicato S, et al. Hyperdynamic circulation in acute liver failure: reperfusion syndrome and outcome following liver transplantation. Transpl Proc. 2010;42:1197–9.
25.
Zurück zum Zitat Moore K. Renal failure in acute liver failure. Eur J Gastroenterol Hepatol. 1999;11:967–75. Moore K. Renal failure in acute liver failure. Eur J Gastroenterol Hepatol. 1999;11:967–75.
27.
Zurück zum Zitat Guevara M, Ginès P, Bandi JC, et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology. 1998;28:416–22.CrossRefPubMed Guevara M, Ginès P, Bandi JC, et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology. 1998;28:416–22.CrossRefPubMed
28.
Zurück zum Zitat Ruiz-del-Arbol L, Monescillo A, Arocena C, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology. 2005;42:439–47.CrossRefPubMed Ruiz-del-Arbol L, Monescillo A, Arocena C, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology. 2005;42:439–47.CrossRefPubMed
29.
Zurück zum Zitat Imoto K, Tanaka M, Goya T, et al. Acute kidney injury is an unfavorable prognostic factor in acute liver failure and is associated with tumor necrosis factor-alpha. Medicine (Baltimore). 2023;102:e35931. Imoto K, Tanaka M, Goya T, et al. Acute kidney injury is an unfavorable prognostic factor in acute liver failure and is associated with tumor necrosis factor-alpha. Medicine (Baltimore). 2023;102:e35931.
30.
Zurück zum Zitat Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014;60:197–209.CrossRefPubMed Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014;60:197–209.CrossRefPubMed
31.
Zurück zum Zitat Navasa M, Follo A, Filella X, et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology. 1998;27:1227–32.CrossRefPubMed Navasa M, Follo A, Filella X, et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology. 1998;27:1227–32.CrossRefPubMed
32.
Zurück zum Zitat Maiwall R, Chandel SS, Wani Z, Kumar S, Sarin SK. SIRS at admission is a predictor of AKI development and mortality in hospitalized patients with severe alcoholic hepatitis. Dig Dis Sci. 2016;61:920–9. Maiwall R, Chandel SS, Wani Z, Kumar S, Sarin SK. SIRS at admission is a predictor of AKI development and mortality in hospitalized patients with severe alcoholic hepatitis. Dig Dis Sci. 2016;61:920–9.
33.
Zurück zum Zitat Rolando N, Harvey F, Brahm J, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology. 1990;11:49–53.CrossRefPubMed Rolando N, Harvey F, Brahm J, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology. 1990;11:49–53.CrossRefPubMed
34.
Zurück zum Zitat Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis. 1996;16:389–402.CrossRefPubMed Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis. 1996;16:389–402.CrossRefPubMed
35.
Zurück zum Zitat Mazer M, Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J Med Toxicol. 2008;4:2–6. Mazer M, Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J Med Toxicol. 2008;4:2–6.
36.
Zurück zum Zitat Mayeux PR, MacMillan-Crow LA. Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury. PharmacolTher. 2012;134:139–55. Mayeux PR, MacMillan-Crow LA. Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury. PharmacolTher. 2012;134:139–55.
37.
Zurück zum Zitat Brown RM, Wang L, Coston TD, et al. Balanced crystalloids versus saline in sepsis. A secondary analysis of the SMART clinical trial. Am J Respir Crit Care Med. 2019;200:1487–95. Brown RM, Wang L, Coston TD, et al. Balanced crystalloids versus saline in sepsis. A secondary analysis of the SMART clinical trial. Am J Respir Crit Care Med. 2019;200:1487–95.
38.
Zurück zum Zitat Weiss E, Paugam-Burtz C, Jaber S. Shock etiologies and fluid management in liver failure. Semin Respir Crit Care Med. 2018;39:538–45. Weiss E, Paugam-Burtz C, Jaber S. Shock etiologies and fluid management in liver failure. Semin Respir Crit Care Med. 2018;39:538–45.
39.
Zurück zum Zitat Volpicelli G, Lamorte A, Tullio M, et al. Point-of-care multiorgan ultrasonography for the evaluation of undifferentiated hypotension in the emergency department. Intensive Care Med. 2013;39:1290–8.CrossRefPubMed Volpicelli G, Lamorte A, Tullio M, et al. Point-of-care multiorgan ultrasonography for the evaluation of undifferentiated hypotension in the emergency department. Intensive Care Med. 2013;39:1290–8.CrossRefPubMed
40.
Zurück zum Zitat Shokoohi H, Boniface KS, Pourmand A, et al. Bedside ultrasound reduces diagnostic uncertainty and guides resuscitation in patients with undifferentiated hypotension. Crit Care Med. 2015;43:2562–9.CrossRefPubMed Shokoohi H, Boniface KS, Pourmand A, et al. Bedside ultrasound reduces diagnostic uncertainty and guides resuscitation in patients with undifferentiated hypotension. Crit Care Med. 2015;43:2562–9.CrossRefPubMed
41.
Zurück zum Zitat Sekiguchi H, Harada Y, Villarraga HR, et al. Focused cardiac ultrasound in the early resuscitation of severe sepsis and septic shock: a prospective pilot study. J Anesth. 2017;31:487–93.CrossRefPubMed Sekiguchi H, Harada Y, Villarraga HR, et al. Focused cardiac ultrasound in the early resuscitation of severe sepsis and septic shock: a prospective pilot study. J Anesth. 2017;31:487–93.CrossRefPubMed
42.
Zurück zum Zitat Audimoolam VK, McPhail MJW, Willars C, et al. Predicting fluid responsiveness in acute liver failure. Anesth Analg. 2017;124:480–6. Audimoolam VK, McPhail MJW, Willars C, et al. Predicting fluid responsiveness in acute liver failure. Anesth Analg. 2017;124:480–6.
43.
Zurück zum Zitat Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316:509–18. Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316:509–18.
45.
Zurück zum Zitat Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J. 1979;2:1097–100. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J. 1979;2:1097–100.
46.
Zurück zum Zitat Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007;35:2498–508. Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007;35:2498–508.
47.
Zurück zum Zitat Davenport A. Is there a role for continuous renal replacement therapies in patients with liver and renal failure? Kidney Int Suppl. 1999;72:S62–6.CrossRef Davenport A. Is there a role for continuous renal replacement therapies in patients with liver and renal failure? Kidney Int Suppl. 1999;72:S62–6.CrossRef
48.
Zurück zum Zitat Davenport A. Continuous renal replacement therapies in patients with liver disease. Semin Dial. 2009;22:169–72. Davenport A. Continuous renal replacement therapies in patients with liver disease. Semin Dial. 2009;22:169–72.
49.
Zurück zum Zitat Khan R, Koppe S. Modern management of acute liver failure. Gastroenterol Clin N Am. 2018;47:313–26. Khan R, Koppe S. Modern management of acute liver failure. Gastroenterol Clin N Am. 2018;47:313–26.
50.
Zurück zum Zitat Slack AJ, Auzinger G, Willars C, et al. Ammonia clearance with hemofiltration in adults with liver disease. Liver Int. 2014;34:42–8.CrossRefPubMed Slack AJ, Auzinger G, Willars C, et al. Ammonia clearance with hemofiltration in adults with liver disease. Liver Int. 2014;34:42–8.CrossRefPubMed
51.
Zurück zum Zitat Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology. 2018;67:711–20.CrossRefPubMed Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology. 2018;67:711–20.CrossRefPubMed
52.
Zurück zum Zitat Arora A, Kumar A, Prasad N, et al. INASL-ISN Joint Position Statements on management of patients with simultaneous liver and kidney disease. J Clin Exp Hepatol. 2021;11:354–86. Arora A, Kumar A, Prasad N, et al. INASL-ISN Joint Position Statements on management of patients with simultaneous liver and kidney disease. J Clin Exp Hepatol. 2021;11:354–86.
53.
Zurück zum Zitat Sivilotti ML, Juurlink DN, Garland JS, et al. Antidote removal during haemodialysis for massive acetaminophen overdose. Clin Toxicol (Phila). 2013;51:855–63. Sivilotti ML, Juurlink DN, Garland JS, et al. Antidote removal during haemodialysis for massive acetaminophen overdose. Clin Toxicol (Phila). 2013;51:855–63.
54.
Zurück zum Zitat William B, Anna H, Amit G, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013;59:74–80.CrossRef William B, Anna H, Amit G, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013;59:74–80.CrossRef
55.
Zurück zum Zitat Raquel Olivo, Guarrera James V, Pyrsopoulos Nikalaos T. Liver transplantation for acute liver failure. Clin Liver Dis. 2018;56:409–17. Raquel Olivo, Guarrera James V, Pyrsopoulos Nikalaos T. Liver transplantation for acute liver failure. Clin Liver Dis. 2018;56:409–17.
56.
Zurück zum Zitat Barshes NR, Lee TC, Balkrishnan R, Karpen SJ, Carter BA, Goss JA. Risk stratification of adult patients undergoing orthotopic liver transplantation for fulminant hepatic failure. Transplantation. 2006;81:195–201.CrossRefPubMed Barshes NR, Lee TC, Balkrishnan R, Karpen SJ, Carter BA, Goss JA. Risk stratification of adult patients undergoing orthotopic liver transplantation for fulminant hepatic failure. Transplantation. 2006;81:195–201.CrossRefPubMed
57.
Zurück zum Zitat Leithead JA, Ferguson JW, Bates CM, Davidson JS, Simpson KJ, Hayes PC. Chronic kidney disease after liver transplantation for acute liver failure is not associated with perioperative renal dysfunction. Am J Transplant. 2011;11:1905–15.CrossRefPubMed Leithead JA, Ferguson JW, Bates CM, Davidson JS, Simpson KJ, Hayes PC. Chronic kidney disease after liver transplantation for acute liver failure is not associated with perioperative renal dysfunction. Am J Transplant. 2011;11:1905–15.CrossRefPubMed
58.
Zurück zum Zitat Nadim MK, Annanthapanyasut W, Matsuoka L, et al. Intraoperative hemodialysis during liver transplantation: a decade of experience. Liver Transpl. 2014;20:756–64.CrossRefPubMed Nadim MK, Annanthapanyasut W, Matsuoka L, et al. Intraoperative hemodialysis during liver transplantation: a decade of experience. Liver Transpl. 2014;20:756–64.CrossRefPubMed
59.
Zurück zum Zitat Knight SR, Oniscu GC, Devey L, Simpson KJ, Wigmore SJ, Harrison EM. Use of renal replacement therapy may influence graft outcomes following liver transplantation for acute liver failure: a propensity-score matched population-based retrospective cohort study. PLoS One. 2016;11:e0148782. Knight SR, Oniscu GC, Devey L, Simpson KJ, Wigmore SJ, Harrison EM. Use of renal replacement therapy may influence graft outcomes following liver transplantation for acute liver failure: a propensity-score matched population-based retrospective cohort study. PLoS One. 2016;11:e0148782.
60.
Zurück zum Zitat Kim TS, Kim JM, Kwon CHD, Kim SJ, Joh JW, Lee SK. Prognostic factors predicting poor outcome in living-donor liver transplantation for fulminant hepatic failure. Transplant Proc. 2017;49:1118–22.CrossRefPubMed Kim TS, Kim JM, Kwon CHD, Kim SJ, Joh JW, Lee SK. Prognostic factors predicting poor outcome in living-donor liver transplantation for fulminant hepatic failure. Transplant Proc. 2017;49:1118–22.CrossRefPubMed
Metadaten
Titel
Acute kidney injury in acute liver failure: A narrative review
verfasst von
Brij Sharma
Anshul Bhateja
Rajesh Sharma
Ashish Chauhan
Vishal Bodh
Publikationsdatum
05.04.2024
Verlag
Springer India
Erschienen in
Indian Journal of Gastroenterology
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-024-01559-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.